MARKET RADAR
SENSEX     NIFTY      Refresh
You are here : MONEYCONTROL > MARKETS > SHARE PRICE > PHARMACEUTICALS > COMPANY INFO - AJANTA PHARMA

Ajanta Pharma

BSE: 532331 | NSE: AJANTPHARM | ISIN: INE031B01031 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
May 20, 13:26
946.00
-8.50 (-0.89%)
VOLUME 20,643
AVERAGE VOLUME
5-Day 101,702
10-Day 120,460
30-Day 101,042
VOLUME SHOCKER
5-Day 101,702
10-Day 120,460
30-Day 101,042
Prev. Close
954.50
Open Price
959.55
Bid PRICE (QTY.)
944.15 (10)
Offer PRICE (Qty.)
946.00 (10)
Today’s Low/High 941.15 966.00
52 Wk Low/High 284.13 1000.00
LIVE
NSE
May 20, 13:26
946.40
-7.15 (-0.75%)
VOLUME 39,367
AVERAGE VOLUME
5-Day 243,178
10-Day 281,400
30-Day 260,199
VOLUME SHOCKER
5-Day 243,178
10-Day 281,400
30-Day 260,199
Prev. Close
953.55
Open Price
958.90
Bid PRICE (QTY.)
944.40 (25)
Offer PRICE (Qty.)
946.95 (10)
Today’s Low/High 940.30 966.90
52 Wk Low/High 278.03 1002.00
Action in Ajanta Pharma
MARKET CAP (Rs Cr)
2,216.84
*P/E
21.92
*BOOK VALUE (Rs)
159.12
DIV (%)
75.00%
Market Lot
1
INDUSTRY P/E
28.46
*EPS (TTM)
43.15
*P/C
16.56
*PRICE/BOOK
5.95
DIV YIELD.(%)
0.40%
FACE VALUE (Rs)
5.00
DELIVERABLES (%)
14.85 new
DELIVERY AVERAGES
3-Day 15.15%
5-Day 12.40%
8-Day 14.95%
* Based on standalone numbers
Track Ajanta Pharma on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL
Would you bet on Ajanta Pharma today?
Test your strategy with virtual money on Moneybhai
Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 277.83 959.55  
High Price 292.50 966.00  
Low Price 277.83 941.15  
Last Price 283.70 946.00 233.45
Volume 37,160 20,643 -44.45
Simple Moving Averages
Days BSE NSE
30 796.92 797.30
50 741.45 741.74
150 542.75 543.02
200 508.29 508.46

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Ajanta Pharma

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
  (Mar '13)
Quarterly
(Mar '13)
Yearly
Net Sales 249.44 839.20
Other Income 6.28 7.41
PBDIT 74.71 214.69
Net Profit 27.09 101.12

Annual Report

Download in PDF format 2012 |2011
Balance Sheet
(Mar '13)
(In Rs Cr)
Total Share Capital 11.80
Net Worth 271.84
Total Debt 162.23
Net Block 236.56
Investments 17.05
Net Current Assets 177.93
Total Assets 434.05
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 981.35 1.66 997.95 569.00 101,626.84
Dr Reddys Labs 2056.90 -1.00 2150.90 1555.00 34,933.66
Lupin 766.65 -4.68 810.80 519.00 34,318.10
Cipla 418.05 -1.55 435.00 305.00 33,566.13
GlaxoSmithKline 2300.00 -0.91 2522.00 2005.00 19,481.69
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 13Dec' 12Jun' 12Mar' 12
Promoter73.0072.7071.8470.13
FII1.531.341.290.59
DII0.080.030.000.01
Others25.3925.9326.8729.27
Total100.00100.00100.00100.00
Mutual Funds Holding
No Mutual Funds Holding the share
Company Information
REGISTERED OFFICE
Address
"Ajanta House", Charkop,,Kandivli (West)
City
Mumbai
State
Maharashtra
Pin Code
400067
Tel. No.
022-66061000 022-66061204
Fax No.
022-66061200 022-66061300
REGISTRARS
Name
Link Intime India Pvt. Ltd.
Address
C-13, Pannalal Silk Mill Compound, LBS Marg, Bhandup (West)
City
Mumbai - 400078
State
Maharashtra
Tel. No.
022-25960320
Fax No.
022-25960329
MANAGEMENT
Name
Designation
Mannalal B Agrawal
Chairman
Purushottam B Agrawal
Vice Chairman
Madhusudan B Agrawal
Vice Chairman
Yogesh M Agrawal
Managing Director
Anil Kumar
Director
Message Board & Community
Quick Links for Ajanta Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.